Targeting somatostatin receptors in the treatment of neuroendocrine tumors

nav.hidden, nav ul [x-cloak], nav ul li ul { display: block !important; } This website requires Javascript for some parts to function properly. Your experience may vary.

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential Essential cookies enable basic functions and are necessary for the website to function properly. Marketing Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Log out

Change Cookie Settings

Forgot Password? Click here

Cookie consent is required to register and log in

I am a Healthcare professional outside US

Subscribe me to the regular newsletter

Notice: The content of this website is not intended for U.S. residents.

This website has implemented reCAPTCHA v3 and your use of reCAPTCHA v3 is subject to the Google Privacy Policy and Terms of Use.

Log out

Change Cookie Settings

Forgot Password? Click here

Cookie consent is required to register and log in

I am a Healthcare professional outside US

Subscribe me to the regular newsletter

Notice: The content of this website is not intended for U.S. residents.

This website has implemented reCAPTCHA v3 and your use of reCAPTCHA v3 is subject to the Google Privacy Policy and Terms of Use.

Targeting somatostatin receptors in the treatment of neuroendocrine tumors

Somatostatin signaling is an important pathway involved in the pathophysiology of neuroendocrine tumors (NETs) that allows a personalized theranostic approach to their management.

Back Download Slide-Kit

Related Assets

Infographics

Aug 2023

Mode of action

Highly precise radiopharmaceuticals can be used to effectively diagnose or treat tumors expressing specific receptors on their surface. Watch the video to learn more about their mode of action (MoA).

NET RPT SSTR

Infographics

Sep 2024

COMPOSE Phase III Study

NET RPT SSTR

Infographics

Sep 2024

Targeted Radiopharmaceutical Therapy

Learn more about targeted radiopharmaceutical therapy and the mechanism of action of radiotherapeutic agents used for the treatment of tumors expressing specific receptors on their surface.

RPT NET SSTR